Autonomic Nervous System Monitoring in Overtraining Syndrome Detection

Overtraining Syndrome (OTS) manifests as prolonged performance decline, fatigue, mood disturbance, and hormonal dysregulation due to excessive training load without adequate recovery. Early detection is critical to prevent long-term athlete impairment. Autonomic Nervous System (ANS) monitoring provides non-invasive, objective metrics for identifying dysregulation preceding clinical symptoms. ANS comprises Sympathetic Nervous System (SNS) and Parasympathetic Nervous System (PNS), regulating homeostasis via effector organs (e.g., heart, vasculature). Heart Rate Variability (HRV) is the gold-standard ANS biomarker, reflecting beat-to-beat fluctuations influenced by PNS (vagal) tone. High HRV indicates robust recovery capacity and PNS dominance; low HRV suggests SNS dominance, stress accumulation, and reduced adaptability. Time-domain metrics: SDNN (standard deviation of NN intervals), RMSSD (root mean square of successive differences), pNN50 (proportion of NN50). Frequency-domain: LF (low frequency: 0.04–0.15 Hz, mixed SNS/PNS), HF (high frequency: 0.15–0.4 Hz, PNS-mediated respiratory sinus arrhythmia), LF/HF ratio (sympathovagal balance proxy). Daily HRV tracking via wearable photoplethysmography (PPG) or ECG enables longitudinal trend analysis. Acute decreases in RMSSD/HF post-intense training are normal; sustained suppression (>72h) indicates incomplete recovery. Morning HRV (measured supine, post-wake) minimizes confounders. Baseline establishment requires 7–14 days of stable training. Deviation thresholds: >3 SD decline in lnRMSSD from baseline signals high fatigue risk. Orthostatic testing (HR/HRV response to postural change) enhances sensitivity: excessive HR increase (>10–15 bpm) and HRV suppression upon standing indicate ANS imbalance. Additional ANS markers: resting Heart Rate (RHR) elevation (>5–10 bpm above baseline), Heart Rate Recovery (HRR) delay (>40 bpm drop at 1-min post-exercise indicates poor vagal reactivation). Contextual data integration (sleep quality, Training Load [TL], Perceived Exertion [RPE], Mood State [POMS]) improves specificity. TL quantified via TRIMP (Training Impulse), sRPE (session RPE), or external load (e.g., GPS). Machine Learning (ML) models (e.g., Random Forest, LSTM) integrate multivariate ANS + contextual inputs to classify overreaching (OR) vs. OTS. Non-functional Overreaching (NFOR) shows transient ANS disruption; OTS exhibits prolonged HRV suppression, elevated RHR, blunted HRR, and mood disturbances persisting weeks post-taper. Functional Overreaching (FOR) is adaptive, short-term performance dip with full recovery. ANS monitoring pitfalls: hydration status, caffeine, alcohol, illness, and circadian rhythm affect HRV. Standardized measurement protocols are essential. Wearable accuracy varies; ECG > chest-strap > wrist-PPG. Validation against laboratory-grade systems recommended. Current State of Art (SOTA): real-time ANS analytics platforms (e.g., HRV4Training, Omegawave, WHOOP) enable field deployment. Research gaps: individualized thresholding, sex-specific responses (females show greater HRV variability due to hormonal flux), youth athlete applicability. Emerging biomarkers: Pulse Arrival Time (PAT), Skin Conductance (SC), Baroreflex Sensitivity (BRS). PAT inversely correlates with blood pressure; SC reflects SNS sweat gland activity. BRS, though lab-intensive, measures cardiovascular stability. Practical Application: integrate daily HRV + RHR into monitoring systems. Alert thresholds trigger coach review. Combine with subjective wellness questionnaires (Hooper Index). Implement micro-tapers upon ANS warning signs. Preventive protocols reduce OTS incidence by 40–60% in elite cohorts. ANS monitoring is not standalone; used within holistic athlete management framework. Future: multimodal sensor fusion, AI-driven early warning systems, genotype-phenotype interaction models (e.g., COMT polymorphism affecting stress response). Expert consensus: ANS metrics are early-warning indicators, not diagnostic tools. Clinical OTS diagnosis requires exclusion of medical/psychiatric conditions (e.g., anemia, depression). ANS-guided periodization optimizes performance: HRV-informed training adjustments improve competition outcomes by enhancing adaptation timing. Limitations: inter-individual variability, lack of universal norms, cost/access barriers in low-resource settings. Conclusion: ANS monitoring, primarily via HRV, is a validated, scalable tool for OTS risk stratification. Enables proactive intervention, minimizing maladaptation. Foundational in modern sports-science athlete support programs.